{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T21:42:51Z","timestamp":1763070171912,"version":"3.45.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clp.2025.08.002","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T20:30:09Z","timestamp":1759955409000},"page":"633-653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiology Overview of Pulmonary Hypertension Management in the Neonatal Intensive Care Unit"],"prefix":"10.1016","volume":"52","author":[{"given":"Rebecca J.","family":"Kameny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel K.","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clp.2025.08.002_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01345-2024","article-title":"Embracing the challenges of neonatal and paediatric pulmonary hypertension","volume":"64","author":"Ivy","year":"2024","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.clp.2025.08.002_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clp.2025.08.002_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpeds.2022.08.027","article-title":"Pulmonary hypertension in children with Down Syndrome: results from the pediatric pulmonary hypertension network registry","volume":"252","author":"Hopper","year":"2023","journal-title":"J Pediatr"},{"key":"10.1016\/j.clp.2025.08.002_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpeds.2019.06.053","article-title":"Morbidity of persistent pulmonary hypertension of the newborn in the first year of life","volume":"213","author":"Steurer","year":"2019","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.clp.2025.08.002_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.clp.2021.05.009","article-title":"Pathophysiology and management of persistent pulmonary hypertension of the newborn","volume":"48","author":"Singh","year":"2021","journal-title":"Clin Perinatol"},{"issue":"4","key":"10.1016\/j.clp.2025.08.002_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2022.101367","article-title":"Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension","volume":"27","author":"Cookson","year":"2022","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1165","article-title":"Persistent pulmonary hypertension of the newborn in late preterm and term infants in California","volume":"139","author":"Steurer","year":"2017","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.clp.2025.08.002_bib8","doi-asserted-by":"crossref","first-page":"F554","DOI":"10.1136\/archdischild-2017-313778","article-title":"Persistent pulmonary hypertension of the newborn in extremely preterm infants: a Japanese cohort study","volume":"103","author":"Nakanishi","year":"2018","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.clp.2025.08.002_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jpeds.2022.07.039","article-title":"Clinical significance of early pulmonary hypertension in preterm infants","volume":"251","author":"Arjaans","year":"2022","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.clp.2025.08.002_bib10","first-page":"143","article-title":"The first breaths of life: imaging studies of the human infant during neonatal transition","volume":"16","author":"van Vonderen","year":"2015","journal-title":"Paediatr Respir Rev"},{"issue":"14","key":"10.1016\/j.clp.2025.08.002_bib11","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1055\/a-1711-0778","article-title":"Evidence-based guidelines for acute stabilization and management of neonates with persistent pulmonary hypertension of the newborn","volume":"40","author":"Ball","year":"2023","journal-title":"Am J Perinatol"},{"issue":"9","key":"10.1016\/j.clp.2025.08.002_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199702273360902","article-title":"Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The inhaled nitric oxide study group","volume":"336","author":"Roberts","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clp.2025.08.002_bib13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00134-003-2122-3","article-title":"Inhaled nitric oxide therapy in neonates and children: reaching a European consensus","volume":"30","author":"Macrae","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clp.2025.08.002_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpeds.2015.11.050","article-title":"Recommendations for the use of inhaled nitric oxide therapy in premature newborns with severe pulmonary hypertension","volume":"170","author":"Kinsella","year":"2016","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1086\/685080","article-title":"Iloprost drug delivery during infant conventional and high-frequency oscillatory ventilation","volume":"6","author":"DiBlasi","year":"2016","journal-title":"Pulm Circ"},{"issue":"8","key":"10.1016\/j.clp.2025.08.002_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ppul.21619","article-title":"Nebulized iloprost and noninvasive respiratory support for impending hypoxaemic respiratory failure in formerly preterm infants: a case series","volume":"47","author":"Piastra","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"10.1016\/j.clp.2025.08.002_bib17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1055\/s-0038-1676483","article-title":"Inhaled epoprostenol for pulmonary hypertension treatment in neonates: a 12-Year experience","volume":"36","author":"Berger-Caron","year":"2019","journal-title":"Am J Perinatol"},{"issue":"21","key":"10.1016\/j.clp.2025.08.002_bib18","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric pulmonary hypertension: guidelines from the American heart association and American thoracic society","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.clp.2025.08.002_bib19","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1164\/rccm.200605-694OC","article-title":"Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children","volume":"174","author":"Namachivayam","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.clp.2025.08.002_bib20","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/jp.2011.157","article-title":"A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn","volume":"32","author":"Mohamed","year":"2012","journal-title":"J Perinatol"},{"key":"10.1016\/j.clp.2025.08.002_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jpeds.2016.06.078","article-title":"Bosentan as adjunctive therapy for persistent pulmonary hypertension of the newborn: results of the randomized multicenter placebo-controlled exploratory trial","volume":"177","author":"Steinhorn","year":"2016","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.clp.2025.08.002_bib22","first-page":"463","article-title":"Extracorporeal life support organization (ELSO): guidelines for neonatal respiratory failure","volume":"66","author":"Wild","year":"2020","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"issue":"Suppl 2","key":"10.1016\/j.clp.2025.08.002_bib23","doi-asserted-by":"crossref","first-page":"ii49","DOI":"10.1136\/heartjnl-2015-308591","article-title":"Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric pulmonary Vascular disease network, endorsed by ISHLT and DGPK","volume":"102","author":"Hilgendorff","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.clp.2025.08.002_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2024.114131","article-title":"Defining the typical course of persistent pulmonary hypertension of the newborn: when to think beyond reversible causes","volume":"273","author":"Tsoi","year":"2024","journal-title":"J Pediatr"},{"key":"10.1016\/j.clp.2025.08.002_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1356157","article-title":"Diagnosis, management and long term cardiovascular outcomes of phenotypic profiles in pulmonary hypertension associated with congenital diaphragmatic hernia","volume":"12","author":"Chaudhari","year":"2024","journal-title":"Front Pediatr"},{"key":"10.1016\/j.clp.2025.08.002_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jpeds.2018.04.052","article-title":"Treprostinil improves persistent pulmonary hypertension associated with congenital diaphragmatic hernia","volume":"200","author":"Lawrence","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.clp.2025.08.002_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2023.113490","article-title":"Failure to normalize biventricular function is associated with extracorporeal membrane oxygenation use in neonates with congenital diaphragmatic hernia","volume":"260","author":"Le","year":"2023","journal-title":"J Pediatr"},{"key":"10.1016\/j.clp.2025.08.002_bib28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jpeds.2018.01.043","article-title":"Bronchopulmonary dysplasia: executive summary of a workshop","volume":"197","author":"Higgins","year":"2018","journal-title":"J Pediatr"},{"issue":"10 Pt 1","key":"10.1016\/j.clp.2025.08.002_bib29","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1164\/ajrccm.164.10.2109111c","article-title":"Bronchopulmonary dysplasia: \u201ca vascular hypothesis\u201d","volume":"164","author":"Abman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.clp.2025.08.002_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.semperi.2023.151817","article-title":"Bronchopulmonary dysplasia - associated pulmonary hypertension: an updated review","volume":"47","author":"El-Saie","year":"2023","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.clp.2025.08.002_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MOP.0000000000001459","article-title":"Why some and not others? Understanding vascular phenotypes in genetic developmental lung diseases","author":"Steffes","year":"2025","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.clp.2025.08.002_bib32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/ppul.24637","article-title":"Genes that drive the pathobiology of pediatric pulmonary arterial hypertension","volume":"56","author":"Welch","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.clp.2025.08.002_bib33","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00639-2024","article-title":"An interdisciplinary consensus approach to pulmonary hypertension in developmental lung disease","volume":"64","author":"Varghese","year":"2024","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pedneo.2016.09.011","article-title":"Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn","volume":"59","author":"Lai","year":"2018","journal-title":"Pediatr Neonatol"},{"issue":"3","key":"10.1016\/j.clp.2025.08.002_bib35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clp.2020.05.006","article-title":"Updates on management for acute and chronic phenotypes of neonatal pulmonary hypertension","volume":"47","author":"Ruoss","year":"2020","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.clp.2025.08.002_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpeds.2017.05.029","article-title":"Evaluation and management of pulmonary hypertension in children with bronchopulmonary dysplasia","volume":"188","author":"Krishnan","year":"2017","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.clp.2025.08.002_bib37","first-page":"572","article-title":"Pulmonary hypertension in preterm infants: results of a prospective screening program","volume":"37","author":"Weismann","year":"2017","journal-title":"J Perinatol Off J Calif Perinat Assoc"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ppul.22797","article-title":"Pulmonary hypertension in bronchopulmonary dysplasia: clinical findings, cardiovascular anomalies and outcomes","volume":"49","author":"del Cerro","year":"2014","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"10.1016\/j.clp.2025.08.002_bib39","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/ppul.23679","article-title":"Pulmonary vein stenosis of ex-premature infants with pulmonary hypertension and bronchopulmonary dysplasia, epidemiology, and survival from a multicenter cohort","volume":"52","author":"Mahgoub","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.clp.2025.08.002_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000499082","article-title":"Accuracy of brain natriuretic peptide for diagnosing pulmonary hypertension in severe bronchopulmonary dysplasia","volume":"116","author":"Avitabile","year":"2019","journal-title":"Neonatology"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1086\/685102","article-title":"Cardiac catheterization in children with pulmonary hypertensive vascular disease: consensus statement from the pulmonary vascular research institute, pediatric and congenital heart disease task forces","volume":"6","author":"del Cerro","year":"2016","journal-title":"Pulm Circ"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12574-021-00545-6","article-title":"Echocardiography-derived septal curvature correlated with invasive hemodynamics in pediatric pulmonary hypertension","volume":"20","author":"Critser","year":"2022","journal-title":"J Echocardiogr"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1164\/rccm.201904-0826OC","article-title":"Cardiac magnetic resonance imaging evaluation of neonatal bronchopulmonary dysplasia-associated pulmonary hypertension","volume":"201","author":"Critser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"7\u20138","key":"10.1016\/j.clp.2025.08.002_bib44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.diii.2024.01.009","article-title":"4D flow cardiac MRI to assess pulmonary blood flow in patients with pulmonary arterial hypertension associated with congenital heart disease","volume":"105","author":"Valdeolmillos","year":"2024","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.clp.2025.08.002_bib45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijcard.2015.10.087","article-title":"Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension)","volume":"203","author":"Beghetti","year":"2016","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.clp.2025.08.002_bib46","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1513\/AnnalsATS.202108-998OC","article-title":"Cardiac catheterization and hemodynamics in a multicenter cohort of children with pulmonary hypertension","volume":"19","author":"Rosenzweig","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"9","key":"10.1016\/j.clp.2025.08.002_bib47","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1164\/rccm.200310-1483OC","article-title":"Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia","volume":"170","author":"Mourani","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib48","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03337-2020","article-title":"Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry","volume":"59","author":"Abman","year":"2022","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.clp.2025.08.002_bib49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41372-018-0303-8","article-title":"Death or resolution: the \u201cnatural history\u201d of pulmonary hypertension in bronchopulmonary dysplasia","volume":"39","author":"Altit","year":"2019","journal-title":"J Perinatol"},{"issue":"2","key":"10.1016\/j.clp.2025.08.002_bib50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.110.016667","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.clp.2025.08.002_bib51","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.healun.2019.06.022","article-title":"Updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT","volume":"38","author":"Hansmann","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.clp.2025.08.002_bib52","first-page":"CD000399","article-title":"Nitric oxide for respiratory failure in infants born at or near term","author":"Finer","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib53","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00000542-199907000-00041","article-title":"Sildenafil ameliorates effects of inhaled nitric oxide withdrawal","volume":"91","author":"Atz","year":"1999","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.clp.2025.08.002_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1047951110001745","article-title":"Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease","volume":"21","author":"Humpl","year":"2011","journal-title":"Cardiol Young"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1542\/hpeds.2015-0076","article-title":"Sildenafil treatment of infants with bronchopulmonary Dysplasia\u2013Associated pulmonary hypertension","volume":"6","author":"Backes","year":"2016","journal-title":"Hosp Pediatr"},{"issue":"3","key":"10.1016\/j.clp.2025.08.002_bib56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jpeds.2008.09.021","article-title":"Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease","volume":"154","author":"Mourani","year":"2009","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.clp.2025.08.002_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12133","article-title":"Riociguat in children with pulmonary arterial hypertension: the PATENT\u2013CHILD study","volume":"12","author":"Garc\u00eda Aguilar","year":"2022","journal-title":"Pulm Circ"},{"key":"10.1016\/j.clp.2025.08.002_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.1014922","article-title":"Novel use of riociguat in infants with severe pulmonary arterial hypertension unable to wean from inhaled nitric oxide","volume":"10","author":"Domingo","year":"2022","journal-title":"Front Pediatr"},{"issue":"9","key":"10.1016\/j.clp.2025.08.002_bib59","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of Ambrisentan plus Tadalafil in pulmonary arterial hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.clp.2025.08.002_bib60","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1017\/S1047951123004456","article-title":"Bosentan in the treatment of persistent pulmonary hypertension in newborns: a systematic review and meta-analysis","volume":"34","author":"Gao","year":"2024","journal-title":"Cardiol Young"},{"issue":"4","key":"10.1016\/j.clp.2025.08.002_bib61","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/674762","article-title":"Safety of epoprostenol and treprostinil in children less than 12 months of age","volume":"3","author":"McIntyre","year":"2013","journal-title":"Pulm Circ"},{"issue":"6","key":"10.1016\/j.clp.2025.08.002_bib62","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1067\/mpd.2002.129849","article-title":"Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide","volume":"141","author":"Kelly","year":"2002","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib63","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1542\/peds.2013-2330","article-title":"Subcutaneous treprostinil for pulmonary hypertension in chronic lung disease of infancy","volume":"134","author":"Ferdman","year":"2014","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib64","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01347-2022","article-title":"Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.clp.2025.08.002_bib65","doi-asserted-by":"crossref","first-page":"e1643","DOI":"10.1542\/peds.2011-1417","article-title":"Treatment of severe pulmonary hypertension in the setting of the large patent ductus arteriosus","volume":"131","author":"Niu","year":"2013","journal-title":"Pediatrics"},{"issue":"20","key":"10.1016\/j.clp.2025.08.002_bib66","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2014.02.575","article-title":"Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies","volume":"63","author":"Zijlstra","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.clp.2025.08.002_bib67","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1164\/rccm.201406-1052OC","article-title":"Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry","volume":"190","author":"del Cerro Mar\u00edn","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"9815","key":"10.1016\/j.clp.2025.08.002_bib68","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(11)61621-8","article-title":"Clinical features of paediatric pulmonary hypertension: a registry study","volume":"379","author":"Berger","year":"2012","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"10.1016\/j.clp.2025.08.002_bib69","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/rccm.202110-2428OC","article-title":"Twenty-year experience and outcomes in a national pediatric pulmonary hypertension service","volume":"206","author":"Constantine","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib70","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpeds.2012.12.036","article-title":"Outcomes of congenital diaphragmatic hernia in the modern era of management","volume":"163","author":"Wynn","year":"2013","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib71","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCULATIONAHA.111.026591","article-title":"Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ppul.23508","article-title":"Pulmonary hypertension specific treatment in infants with bronchopulmonary dysplasia","volume":"52","author":"Kadmon","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.amjcard.2010.02.023","article-title":"Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies","volume":"106","author":"van Loon","year":"2010","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.clp.2025.08.002_bib74","first-page":"39","article-title":"Ventricular global function index is associated with clinical outcomes in pediatric pulmonary hypertension","volume":"25","author":"Ta","year":"2023","journal-title":"J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson"},{"issue":"4","key":"10.1016\/j.clp.2025.08.002_bib75","article-title":"Cardiac magnetic resonance derived left ventricular eccentricity index and right ventricular mass measurements predict outcome in children with pulmonary arterial hypertension","volume":"10","author":"Haarman","year":"2023","journal-title":"Child Basel Switz"},{"key":"10.1016\/j.clp.2025.08.002_bib76","series-title":"Neonatology questions and controversies: infectious disease, immunology, and pharmacology","first-page":"198","article-title":"Vasodilator drugs for pulmonary hypertension in bronchopulmonary dysplasia (chapter 16)","author":"Sullivan","year":"2023"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510825000594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510825000594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T21:40:32Z","timestamp":1763070032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510825000594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0095510825000594"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2025.08.002","relation":{},"ISSN":["0095-5108"],"issn-type":[{"type":"print","value":"0095-5108"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiology Overview of Pulmonary Hypertension Management in the Neonatal Intensive Care Unit","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2025.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}